124
Participants
Start Date
July 29, 2024
Primary Completion Date
June 27, 2025
Study Completion Date
June 27, 2025
Efinopegdutide
SC injections in dose-escalation regimens potentially including doses of 2 mg, 4 mg, 7 mg, and 10 mg in all arms and 15 mg in the Efinopegdutide Q2W 15 mg arm
Basil Clinical ( Site 0246), Inwood
Velocity Clinical Research Rockville ( Site 0245), Rockville
Lucas Research, Inc ( Site 0204), Morehead City
Southeast Clinical Research Center ( Site 0223), Dalton
AGA Clinical Trials ( Site 0274), Hialeah
Neoclinical Research ( Site 0275), Hialeah
Floridian Clinical Research, LLC ( Site 0208), Miami Lakes
Homestead Associates in Research, Inc. ( Site 0243), Homestead
Excel Medical Clinical Trials ( Site 0268), Boca Raton
Zenos Clinical Research ( Site 0240), Dallas
Texas Clinical Research Institute ( Site 0230), Arlington
Impact Research Institute ( Site 0227), Waco
Houston Research Institute ( Site 0221), Houston
American Research Corporation ( Site 0234), San Antonio
Clinical Trials of Texas, LLC-Clinical Research ( Site 0252), San Antonio
Pinnacle Clinical Research-Clinical Research Coordination ( Site 0229), San Antonio
Pinnacle Clinical Research-Corpus Christi ( Site 0267), Corpus Christi
South Texas Research Institute ( Site 0226), Edinburg
Pinnacle Clinical Research ( Site 0203), Austin
Velocity Clinical Research, Austin ( Site 0201), Austin
Olympus Family Medicine/CCT Research ( Site 0266), Holladay
South Ogden Family Medicine/ CCT Research ( Site 0255), South Ogden
The Institute for Liver Health II dba Arizona Clinical Trial-The Institute for Liver Health ( Site 0, Chandler
The Institute for Liver Health II dba Arizona Liver Health - Peoria ( Site 0224), Peoria
Arizona Liver Health ( Site 0211), Tucson
Del Sol Research Management, LLC ( Site 0209), Tucson
The Machuca Foundation ( Site 0218), Las Vegas
Excel Clinical Research, LLC ( Site 0200), Las Vegas
Velocity Clinical Research, Gardena ( Site 0235), Gardena
Velocity Clinical Research, Huntington Park ( Site 0210), Huntington Park
California Liver Research Institute ( Site 0216), Pasadena
Velocity Clinical Research, Panorama City ( Site 0228), Van Nuys
Gastroenterology and Liver Institute ( Site 0263), Escondido
Acclaim Clinical Research ( Site 0241), San Diego
Velocity Clinical Research, Santa Ana ( Site 0250), Santa Ana
Om Research LLC ( Site 0207), Camarillo
San Juan Bautista School of Medicine - Clinical Research Unit ( Site 0104), Caguas
Klinical Investigations Group-Clinical Research ( Site 0100), San Juan
Pan American Center for Oncology Trials - Ciudadela ( Site 0101), San Juan
Merck Sharp & Dohme LLC
INDUSTRY